InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...

Dr. Clarissa Souza, a board-certified veterinary dermatologist and head of the dermatology and otology service at the University of Illinois Veterinary Teaching Hospital in Urbana. Dr. Clarissa Souza, ...

Please provide your email address to receive an email when new articles are posted on . There are few medications dermatologists can prescribe for pyoderma gangrenosum, a complex wound disease.

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced an oral presentation during the Late-Breaking ...

Missouri lawmakers advanced legislation this week to create a clear pathway for adults with severe mental illness to receive ...

Posters presented at the 2026 AAD Annual Meeting examined bimekizumab for hidradenitis suppurative across various subgroups ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 17 scientific posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting (March 27-31, Denver, ...

The Marshall Police Department (MPD) had received reports of a child who had severe burns that were left untreated by the ...

WSU veterinarians implant a pacemaker to stop a Czech shepherd’s sudden collapses. During the peak of the COVID-19 pandemic, ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

Fundamental research into the mechanisms behind cancers at an institution in Japan is leading to new approaches for tackling these notoriously complex diseases. Every year, up to 20 million people in ...